Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03616587
Title Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer. (SERENA-1)
Acronym SERENA-1
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP

Facility Status City State Zip Country Details
Research Site Aurora Colorado 80045 United States Details
Research Site Sarasota Florida 34232 United States Details
Research Site Philadelphia Pennsylvania 19111 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Salt Lake City Utah 84112 United States Details
Research Site Barcelona 08035 Spain Details
Research Site Barcelona 8036 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Madrid 28050 Spain Details
Research Site Sevilla 41013 Spain Details
Research Site Valencia 46010 Spain Details
Research Site Cambridge CB2 0QQ United Kingdom Details
Research Site Leeds LS9 7TF United Kingdom Details
Research Site London SW2 6JJ United Kingdom Details
Research Site Manchester M20 4GJ United Kingdom Details
Research Site Sutton SM1 2DL United Kingdom Details
Research Site Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field